Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta‐Analysis
Racial and ethnic minorities were disproportionately underrepresented in DBRCTs for potential disease-modifying therapies for PD. Additional efforts are required to increase the racial and ethnic representation in such studies.
Authors
- Conor Fearon (ORCID: https://orcid.org/0000-0002-8172-6094)
- Daniel G. Di Luca (ORCID: https://orcid.org/0000-0002-1356-4919)
- Giovana Barros e Silva Ribeiro (ORCID: https://orcid.org/0009-0005-9798-138X)
- Mwiza Ushe
- Bayram Ece
- Raul Vinícius da Silva
- Farley Reis Rodrigues (ORCID: https://orcid.org/0009-0005-2224-8511)
- Aishwarya Koppanatham (ORCID: https://orcid.org/0009-0000-5737-4474)
- Juan Blas M. Couto
- Gabriel Bolner
- Artur F. Schumacher Schuh
Institutions
- Andhra University (IN)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Universidade Federal de Viçosa (BR)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Washington University in St. Louis (US)
- Mater Misericordiae University Hospital (IE)
- Universidade Federal de Santa Catarina (BR)
- Hospital de Clínicas de Porto Alegre (BR)
- Instituto de Neurología Cognitiva (AR)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/mdc3.70482
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00